ClinicalTrials.gg
CompletedNCT07153081Updated Sep 15, 2025

Wearable-Supported Exercise to Reduce Postpartum Weight

An interventional study of Actigraphy watch intervention in Weight Change, sponsored by KK Women's and Children's Hospital. Completed at 1 site in Singapore. Open to female participants aged 21 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-09-15.

Sponsored by KK Women's and Children's Hospital · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 4 years 10 months after the study started (first participant enrolled Oct 2020, registered Aug 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
49
Allocation
Randomized
Ages
21 Years and older
Sex
Female
01

Study summary

The aim of this study is to examine the effect of walking exercise in postpartum women and to evaluate the weight management intervention by using step tracker. The following hypotheses will be tested:

  1. The intervention in postpartum women would reduce the retention of weight gained during pregnancy and lower the risk factors of chronic disease.
  2. Step tracker is an effective tool in encouraging the postpartum women to do more physical activity.
  3. Higher physical activity is recommended for postpartum women for healthy weight lost.
Read the detailed description

Postpartum is an important phase in the reproductive years of women. Weight retention after childbirth can lead to chronic diseases (CD), including obesity, cardiovascular disease and other metabolic related diseases such as diabetes or high blood pressure. There are some studies suggesting that pedometer is useful to encourage women in increasing their physical activity.

We propose to evaluate the effects of physical activity intervention based on wearable steps tracker and optimal weight loss for postpartum women. It will be a pilot stratified randomized intervention study on 200 postpartum women at KK Women's and Children's Hospital. Women who are above 21 years old and had given birth between 6 weeks and 6 months before will be recruited under the study. Postpartum women who physically fit to participate in moderate intensity walking are eligible to participate in the study. Women who participated in other weight management or physical activity intervention projects will be excluded from the study. Study enrolment will be done at the Specialist Outpatient Clinics for postnatal check-ups.

This was 12-16 weeks randomized, single-center, unblinded intervention study (Figure 1). Participants were allocated in a 1:1 ratio to either the intervention group (Actigraphy watch) or the control group (no Actigraphy watch). All participants received the standard routine postpartum care, physical activity counselling with advice on walking and motivational messages. Randomization was done using sealed envelopes. Eligible participants had baseline measurements taken during the study enrolment and consent taking where anthropometric measurements, and blood samples were collected and various questionnaires were filled out to assess baseline demographics and lifestyle characteristics.

All the participants in the intervention group received an Actigraphy watch to wear all the time except for swimming and showering. Walking advises and motivational text messages will be sent to the study participants by the research team.

Data will be collected through questionnaires and clinical measurements. The questionnaires include socio-economic factors, and self-reported physical activity. Bio-physical measurements will be obtained from anthropometric measurements of participants, are collected from the participants at their follow-up time points. Objective physical activity will be collected using an Actigraphy watch.

02

Conditions studied

  • Weight Change

Keywords

  • postpartum
  • physical activity
  • weight change
  • randomised controlled trial
03

In context

Body Weight Changes

231 studies on the registry are indexed under Body Weight Changes; 30 are open to participants now.

This study's enrollment of 49 is below the median of 80 across 179 interventional studies indexed under Body Weight Changes.

Browse Body Weight Changes studies →

Lead sponsor

KK Women's and Children's Hospital is the lead sponsor of 137 studies on the registry; 33 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Above 21 years old
  2. Viable singleton pregnancies
  3. Physically fit to participate in moderate intensity walking.
  4. Term pregnancy without any sever pregnancy complications. -

Exclusion criteria

Exclusion Criteria:

  • 1. Blood-borne disease patients (e.g. , \& C) 2. Participated in other weight management or physical activity intervention projects.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

Hepatitis B tests

Hepatitis B is a virus that infects the liver. These are separate tests: HBsAg positive usually means a current infection (a recent vaccination can briefly cause it too); total anti-HBc (HBcAb) positive means an infection now or in the past; HBV DNA measures how much virus is in the blood.

Some studies accept a past infection if HBV DNA is undetectable, sometimes with antiviral medicine during the study. Check what this study allows.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
49 participants (actual)

Study arms

  • Experimental
    Actigraphy watch intervention

    All the participants in the intervention group received an Actigraphy watch to wear all the time except for swimming and showering. Walking advises and motivational text messages will be sent to the study participants by the research team.

    Device: Actigraphy watch intervention

  • No intervention
    Standard care group

    Walking advises and motivational text messages will be sent to the study participants by the research team.

Interventions

  • DeviceActigraphy watch intervention

    Participants in this group only will be given an Actigraphy watch to track their physical activity levels.

06

What researchers measure

Primary outcomes

  1. Weight change at the end of the intervention at 10 weeks postpartum

    Using measured weight in kgs

    Time frame: At 8-12 weeks postpartum from baseline (4-8 weeks postpartum)

  2. Weight change at the end of the intervention at 14 weeks postpartum

    Using measured weight in kgs

    Time frame: At 12 to 16 weeks postpartum from baseline ( 4-8 weeks postpartum)

Secondary outcomes

  1. Change in body mass index measures from baseline, 10 weeks postpartum and 14 weeks postpartum

    Calculating body mass index (kg/m2) using height (m) and weight (kg) measures

    Time frame: Baseline (4-8 weeks postpartum), 10 weeks postpartum ( 8-12 weeks postpartum) and 14 weeks postpartum (12-16 weeks postpartum)

  2. Change in waist circumference measures from baseline, 10 weeks postpartum and 14 weeks postpartum

    Using waist circumference measures in cm

    Time frame: Baseline (4-8 weeks postpartum), 10 weeks (8-12 weeks postpartum) and 14 weeks (12-16 weeks postpartum)

  3. Change in waist to hip ratio from baseline, 10 weeks and 14 weeks postpartum

    Using waist circumference and hip measures

    Time frame: Baseline 6 weeks postpartum (4-8 weeks postpartum), 10 weeks postpartum (8-12 weeks postpartum) and 14 weeks postpartum (12-16 weeks postpartum).

  4. Change in body fat mass from baseline, 10 and 14 weeks postpartum

    Using body fat mass percentage measured using the bioelectrical impedance analysis scale

    Time frame: Baseline, 10 weeks postpartum (8-12 weeks postpartum) and 14 weeks (12-16 weeks postpartum)

  5. Change in fasting lipid profile from baseline, 10 weeks and 14 weeks postpartum

    Using fasting lipid profiles (total cholesterol, Low-density lipoprotein (LDL) cholesterol, High-density lipoprotein (HDL) cholesterol, triglycerides) of blood samples in mmol/L

    Time frame: Baseline, 10 weeks (8-12 week postpartum) and 14 weeks (12-16 weeks postpartum)

  6. Change in glucose homeostasis markers from baseline at 10 weeks and 14 weeks postpartum

    Using fasting glucose and fasting insulin from blood samples in mmol/L

    Time frame: Baseline, 10 weeks (8-12 weeks postpartum), and 14 weeks (12-16 weeks postpartum)

  7. Change in blood pressure from baseline at 10 weeks and 14 weeks postpartum

    Using measured systolic and diastolic blood pressure in mm/Hg

    Time frame: At baseline, 10 weeks (8-12 weeks postpartum) and 14 weeks (12-16 weeks postpartum)

  8. Change in self-reported frequency of moderate to vigorous physical activity at baseline, 10 weeks and 14 weeks

    Self-reported data from the International Physical Activity Questionnaire (IPAQ) to assess frequency of moderate to vigorous physical activity.

    Time frame: At baseline, 10 weeks (8-12 weeks postpartum) and 14 weeks (12-16 weeks postpartum).

  9. Change in self-reported duration of moderate to vigorous physical activity at baseline, 10 weeks and 14 weeks

    Self-reported data from the International Physical Activity Questionnaire (IPAQ) to assess duration of moderate to vigorous physical activity..

    Time frame: At baseline, 10 weeks (8-12 weeks postpartum) and 14 weeks (12-16 weeks postpartum).

  10. Change in duration of objective moderate to vigorous physical activity at baseline, 10 weeks and 14 weeks

    MVPA will be assessed using an Actigraphy accelerometer Duration: Average daily/weekly minutes of MVPA (minutes per week).

    Time frame: Baseline, 10 weeks postpartum (8-12 weeks postpartum) and 14 weeks (12-16 weeks).

  11. Change in frequency of objective moderate to vigorous physical activity at baseline, 10 weeks and 14 weeks

    MVPA will be assessed using an Actigraphy accelerometer Frequency: Number of days per week with ≥30 minutes of MVPA (days per week).

    Time frame: Baseline, 10 weeks postpartum (8-12 weeks postpartum) and 14 weeks (12-16 weeks).

07

Study locations

1 site
  • KK Women's and Children's Hospital
    Singapore, 229899, Singapore
08

References and documents

Publications

  • Maturi MS, Afshary P, Abedi P. Effect of physical activity intervention based on a pedometer on physical activity level and anthropometric measures after childbirth: a randomized controlled trial. BMC Pregnancy Childbirth. 2011 Dec 16;11:103. doi: 10.1186/1471-2393-11-103. PubMed 22176722 ↗
  • Davenport MH, Giroux I, Sopper MM, Mottola MF. Postpartum exercise regardless of intensity improves chronic disease risk factors. Med Sci Sports Exerc. 2011 Jun;43(6):951-8. doi: 10.1249/MSS.0b013e3182051155. PubMed 21085038 ↗
  • Quah PL, Tan KH, Tan MH, Chern BSM. Evaluating wearable-supported exercise interventions for reducing postpartum weight: a randomized controlled trial. BMC Pregnancy Childbirth. 2026 Apr 1;26(1):515. doi: 10.1186/s12884-026-08937-1. PubMed 41917836 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — The IPD will not be shared due to privacy concerns and the potential risk of re-identification, especially in a small sample size or a highly specific population

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 15, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07153081
Responsible party
Bernard Chern Su Min (Head & Senior Consultant, KK Women's and Children's Hospital) — Principal investigator
First posted
Sep 3, 2025
Start date
Oct 20, 2020
Primary completion
Sep 12, 2021
Completion
Sep 12, 2021
Last update
Sep 15, 2025

Study contacts

Bernard Su Min Chern, MD
principal investigator · KK Women's and Children's Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion